Updated NCCN Guidelines for multiple myeloma add a dedicated MRD testing framework and expand recommended MRD assessment timepoints. The NCCN has updated its Clinical Practice Guidelines in Oncology ...

Expanded timing includes annual MRD testing during maintenance and after subsequent therapy lines, including following CAR-T, to enable serial assessment rather than single timepoint interpretation.

Updated guidelines establish a dedicated framework for routine MRD assessment across the multiple myeloma patient journey ...

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) highlighted updated National Comprehensive Cancer Network, or NCCN, multiple myeloma guidelines on 17. According to the announcement, the ...

Automated risk assessment has become increasingly popular in the criminal justice system, but a new study published in the American Criminal Law Review assessed the accuracy, validity and predictive ...